Aldurazyme laronidase: Phase III

BMRN and partner GENZ said preliminary analysis of a double-blind, placebo-controlled Phase III trial showed patients given Aldurazyme

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE